NCT01261247 2022-05-24Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaMayo ClinicPhase 2 Completed41 enrolled 8 charts
NCT01658319 2015-08-13Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 1 Completed20 enrolled
NCT01016990 2014-01-10Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaNational Cancer Institute (NCI)Phase 2 Unknown52 enrolled